758 related articles for article (PubMed ID: 1666101)
21. Study of feline leukemia virus immunity.
Charreyre C; Pedersen NC
J Am Vet Med Assoc; 1991 Nov; 199(10):1316-24. PubMed ID: 1666074
[TBL] [Abstract][Full Text] [Related]
22. Diagnosing feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) infection: an update for clinicians.
Westman ME; Malik R; Norris JM
Aust Vet J; 2019 Mar; 97(3):47-55. PubMed ID: 30809813
[TBL] [Abstract][Full Text] [Related]
23. Review of the first feline leukemia virus vaccine.
Pollock VH; Haffer KN
J Am Vet Med Assoc; 1991 Nov; 199(10):1406-9. PubMed ID: 1666092
[No Abstract] [Full Text] [Related]
24. [Epidemiology of FeLV and FIV infection in the Federal Republic of Germany].
Fuchs A; Binzel L; Lonsdorfer M
Tierarztl Prax; 1994 Jun; 22(3):273-7. PubMed ID: 8048038
[TBL] [Abstract][Full Text] [Related]
25. Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine.
Jirjis FF; Davis T; Lane J; Carritt K; Sweeney D; Williams J; Wasmoen T
Vet Ther; 2010; 11(2):E1-6. PubMed ID: 20957616
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a novel nested PCR for the routine diagnosis of feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV).
Arjona A; Barquero N; Doménech A; Tejerizo G; Collado VM; Toural C; Martín D; Gomez-Lucia E
J Feline Med Surg; 2007 Feb; 9(1):14-22. PubMed ID: 16863698
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a killed, whole virion feline leukemia virus vaccine.
Tizard I; Bass EP
J Am Vet Med Assoc; 1991 Nov; 199(10):1410-3. PubMed ID: 1666093
[No Abstract] [Full Text] [Related]
28. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC
Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683
[TBL] [Abstract][Full Text] [Related]
29. Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits.
Westman ME; Malik R; Hall E; Sheehy PA; Norris JM
Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():43-52. PubMed ID: 26459979
[TBL] [Abstract][Full Text] [Related]
30. Feline leukemia virus vaccine development.
Sebring RW; Chu HJ; Chavez LG; Sandblom DS; Hustead DR; Dale B; Wolf D; Acree WM
J Am Vet Med Assoc; 1991 Nov; 199(10):1413-9. PubMed ID: 1666094
[No Abstract] [Full Text] [Related]
31. Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays.
Hofmann-Lehmann R; Tandon R; Boretti FS; Meli ML; Willi B; Cattori V; Gomes-Keller MA; Ossent P; Golder MC; Flynn JN; Lutz H
Vaccine; 2006 Feb; 24(8):1087-94. PubMed ID: 16198454
[TBL] [Abstract][Full Text] [Related]
32. [Vaccination against feline retrovirus infections].
Horzinek MC
Tierarztl Prax; 1996 Apr; 24(2):197-202. PubMed ID: 8650690
[TBL] [Abstract][Full Text] [Related]
33. Enzyme-linked immunosorbent assay methods for detection of feline leukemia virus and feline immunodeficiency virus.
Tonelli QJ
J Am Vet Med Assoc; 1991 Nov; 199(10):1336-9. PubMed ID: 1666077
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and efficacy of a commercial feline leukemia virus vaccine.
Pedersen NC
J Vet Intern Med; 1993; 7(1):34-9. PubMed ID: 8384261
[TBL] [Abstract][Full Text] [Related]
35. An enzyme linked immunosorbent assay (ELISA) for the detection of feline immunodeficiency virus (FIV) antigen in cell culture and FIV specific antibodies in feline serum.
Siebelink CH; Windrich RW; Chu I; Groen J; Weijer K; UytdeHaag FG; Osterhaus AD
Dev Biol Stand; 1990; 72():189-96. PubMed ID: 2178115
[TBL] [Abstract][Full Text] [Related]
36. Panel report on the colloquium on feline leukemia virus/feline immunodeficiency virus: tests and vaccination.
J Am Vet Med Assoc; 1991 Nov; 199(10):1273-7. PubMed ID: 1666068
[No Abstract] [Full Text] [Related]
37. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
[TBL] [Abstract][Full Text] [Related]
38. Early events in the immunopathogenesis of feline retrovirus infections.
Tompkins MB; Nelson PD; English RV; Novotney C
J Am Vet Med Assoc; 1991 Nov; 199(10):1311-5. PubMed ID: 1666073
[TBL] [Abstract][Full Text] [Related]
39. Use of western blot and radioimmunoprecipitation for diagnosis of feline leukemia and feline immunodeficiency virus infections.
Egberink HF; Lutz H; Horzinek MC
J Am Vet Med Assoc; 1991 Nov; 199(10):1339-42. PubMed ID: 1666078
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
Huisman W; Schrauwen EJ; Tijhaar E; Süzer Y; Pas SD; van Amerongen G; Sutter G; Rimmelzwaan GF; Osterhaus AD
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):332-8. PubMed ID: 18952300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
